Filter
Sort
Issue 3
Issue 3

Results from recent studies of two first-in-class antiretrovirals, as well as preliminary results of broadly neutralizing antibody therapies, may expa...

Expired: 03.28.2025
Issue 2
Issue 2

In her Expert Commentary, Dr. Melanie Ward from West Virginia University’s Rockefeller Neuroscience Institute provided analysis of the newer dat...

Expired: 03.07.2025
Issue 1
Issue 1

What does the recent research say about the risk factors for developing MS? How significant is past Epstein-Barr virus/infectious mononucleosis infect...

Expired: 02.01.2025
Issue 2
Issue 2

Stigma. What is it, and where does it come from? How do LGBTQ+ individuals, particularly those with HIV, experience it? How does stigma affect their m...

Expired: 01.11.2025
Issue 1
Issue 1

Among the LGBTQ+ population, why is HIV virologic suppression lower in the transgender and gender-diverse (trans) populations? Why are trans women 66...

Expired: 01.09.2025
Issue 7
Issue 7

Cystic fibrosis and weight gain. For most of their lives, individuals with CF have struggled to gain weight and achieve BMI norms. For most, despite t...

Expired: 12.22.2024
Issue 8
Issue 8

Individuals with cystic fibrosis — adults as well infants and children — have long struggled to gain and maintain their weight. But how ha...

Expired: 12.22.2024
2022 Special Edition, Issue 2
2022 Special Edition, Issue 2

Hepatitis B. It may not be curable yet, but as our knowledge continues to grow, so does our ability to benefit our patients today as we prepare them f...

Expired: 10.19.2024
2022 Special Edition, Issue 1
2022 Special Edition, Issue 1

Hepatitis B. Unlike Hep C, it’s not curable — yet. But as the research continues and the knowledge base continues to grow, the cure gets c...

Expired: 10.19.2024
Issue 12
Issue 12

Treatment-experienced patients with RAMs — resistance-associated mutations — remain a difficult management challenge. Every case of HIV dr...

Expired: 10.10.2024
Issue 12
Issue 12

How aware are clinicians that MS should no longer be considered a “White people only” disease? What roles have race and ethnicity been sho...

Expired: 10.03.2024
Issue 11
Issue 11

For clinicians seeking to provide the most effective HIV management, choosing ART for treatment-experienced patients with resistance-associated mutati...

Expired: 09.26.2024
Issue 11
Issue 11

The widely held belief that “MS rarely affects Black Americans” has been disputed by recent data. Not only has the overall prevalence of m...

Expired: 09.19.2024
Issue 6
Issue 6

The advent of triple CFTR modulator therapy – ETI (elexacaftor/tezacaftor/ivacaftor) — poses a number of clinical questions. Are three age...

Expired: 09.13.2024
Issue 10
Issue 10

Most people living with HIV gain weight when initiating ART. For some, the weight gain signifies a “return to health”; for others, the add...

Expired: 09.06.2024
Issue 10
Issue 10

Where’s the newer MS research leading? How has our understanding of noninflammatory progressive MS changed? How might these findings affect what...

Expired: 08.24.2024